These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


691 related items for PubMed ID: 28695742

  • 1. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â, Souza EE, Costa FC, Meirelles GV, Gonçalves KA, Santos MT, Bressan GC, McComb ME, Costello CE, Whelan SA, Kobarg J.
    J Proteome Res; 2017 Sep 01; 16(9):3147-3157. PubMed ID: 28695742
    [Abstract] [Full Text] [Related]

  • 2. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
    Percherancier Y, Germain-Desprez D, Galisson F, Mascle XH, Dianoux L, Estephan P, Chelbi-Alix MK, Aubry M.
    J Biol Chem; 2009 Jun 12; 284(24):16595-16608. PubMed ID: 19380586
    [Abstract] [Full Text] [Related]

  • 3. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
    Maroui MA, Kheddache-Atmane S, El Asmi F, Dianoux L, Aubry M, Chelbi-Alix MK.
    PLoS One; 2012 Jun 12; 7(9):e44949. PubMed ID: 23028697
    [Abstract] [Full Text] [Related]

  • 4. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
    Fasci D, Anania VG, Lill JR, Salvesen GS.
    Sci Signal; 2015 Jun 09; 8(380):ra56. PubMed ID: 26060329
    [Abstract] [Full Text] [Related]

  • 5. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S, Gärtner A, Kniss A, Stengl A, Behrends C, Rogov VV, Rodriguez MS, Dötsch V, Müller S, Ernst A.
    J Biol Chem; 2017 Sep 15; 292(37):15340-15351. PubMed ID: 28784659
    [Abstract] [Full Text] [Related]

  • 6. SUMOylation of HMGA2: selective destabilization of promyelocytic leukemia protein via proteasome.
    Cao X, Clavijo C, Li X, Lin HH, Chen Y, Shih HM, Ann DK.
    Mol Cancer Ther; 2008 Apr 15; 7(4):923-34. PubMed ID: 18413806
    [Abstract] [Full Text] [Related]

  • 7. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P, Kasyapa CS, Chin SF, Caldas C, Cowell JK.
    Exp Cell Res; 2006 Nov 15; 312(19):3739-51. PubMed ID: 17027752
    [Abstract] [Full Text] [Related]

  • 8. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC, Lee CC, Yao YL, Lai CC, Schmitz ML, Yang WM.
    Sci Rep; 2016 May 23; 6():26509. PubMed ID: 27211601
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK.
    J Immunol; 2015 Sep 01; 195(5):2312-24. PubMed ID: 26223657
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification and Characterization of SUMO-SIM Interactions.
    Husnjak K, Keiten-Schmitz J, Müller S.
    Methods Mol Biol; 2016 Sep 01; 1475():79-98. PubMed ID: 27631799
    [Abstract] [Full Text] [Related]

  • 13. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH, Lussier-Price M, Cappadocia L, Estephan P, Raiola L, Omichinski JG, Aubry M.
    J Biol Chem; 2013 Dec 20; 288(51):36312-27. PubMed ID: 24174529
    [Abstract] [Full Text] [Related]

  • 14. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S, Udagawa O.
    Arch Toxicol; 2022 Feb 20; 96(2):545-558. PubMed ID: 35001170
    [Abstract] [Full Text] [Related]

  • 15. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
    Xu WX, Liu SZ, Wu D, Qiao GF, Yan J.
    Cell Physiol Biochem; 2015 Feb 20; 37(4):1581-91. PubMed ID: 26517826
    [Abstract] [Full Text] [Related]

  • 16. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
    Conde JN, Schutt WR, Mladinich M, Sohn SY, Hearing P, Mackow ER.
    J Virol; 2020 Sep 15; 94(19):. PubMed ID: 32699085
    [Abstract] [Full Text] [Related]

  • 17. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
    Liu Y, Zhao D, Qiu F, Zhang LL, Liu SK, Li YY, Liu MT, Wu D, Wang JX, Ding XQ, Liu YX, Dong CJ, Shao XQ, Yang BF, Chu WF.
    Mol Ther; 2017 Mar 01; 25(3):666-678. PubMed ID: 28143738
    [Abstract] [Full Text] [Related]

  • 18. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
    McManus FP, Bourdeau V, Acevedo M, Lopes-Paciencia S, Mignacca L, Lamoliatte F, Rojas Pino JW, Ferbeyre G, Thibault P.
    Sci Rep; 2018 May 17; 8(1):7754. PubMed ID: 29773808
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
    Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de Thé H, Chen SJ, Chen Z.
    Science; 2010 Apr 09; 328(5975):240-3. PubMed ID: 20378816
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.